Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores
Francis Y. Yao(University of California, San Francisco), John P. Roberts(University of California, San Francisco), David Ly(Cheikh Anta Diop University), Ann Lazar(University of California, San Francisco), Peter Bacchetti(University of California, San Francisco), Ryutaro Hirose(University of Washington), Nancy L. Ascher(University of California, San Francisco), Sammy Saab(Mount Sinai Medical Center), Nathan M. Bass(University of California, San Francisco), Norah A. Terrault(University of Southern California)
Cited by 109
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799
Evidence-Based Incorporation of Serum Sodium Concentration Into MELD
|Gastroenterology|2006|777